Ras Dimer Formation as a New Signaling Mechanism and Potential Cancer Therapeutic Target

Mo Chen, Alec Peters, Tao Huang

  • 1Department of Biomedical Engineering, Knight Cancer Institute, and OHSU Center for Spatial Systems Biomedicine (OCSSB), Oregon Health and Science University, Portland, OR. nan@ohsu.edu.

Insights

Ras GTPases are crucial for cell function and cancer. A new dimer model explains Ras signaling, offering novel therapeutic targets beyond traditional monomer-based approaches.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Oncology

Background:

  • K-, N-, and HRas small GTPases regulate cell physiology and are frequently mutated in human cancers.
  • Targeting hyperactive Ras has been challenging due to limited understanding of its signaling mechanisms.
  • Ras dimers represent a newly recognized mechanism for regulating Ras activity.

Purpose of the Study:

  • To propose a novel dimer model for Ras-mediated effector activation.
  • To contrast the proposed dimer model with existing monomer and multimer models of Ras signaling.
  • To discuss the implications of the Ras dimer model in basic and translational cancer research.

Main Methods:

  • Review and synthesis of existing studies on Ras dimerization.
  • Development of a theoretical dimer model for Ras signaling.
  • Comparative analysis of dimer, monomer, and multimer models.

Main Results:

  • Ras proteins form dimers on the cell membrane, representing a key regulatory mechanism.
  • The proposed dimer model provides an alternative framework for understanding Ras-driven effector activation.
  • This model contrasts with established theories of Ras signaling via monomers or large multimers.

Conclusions:

  • Ras dimerization is a biologically relevant mechanism influencing cell signaling and cancer.
  • The dimer model offers new perspectives for developing targeted cancer therapies.
  • Further research into Ras dimerization could unlock novel therapeutic strategies for Ras-mutated cancers.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
20.8K